Alembic Pharmaceuticals' API-III facility inspection occurred March 17-21, 2025. The company produces globally approved generic drugs with USFDA certified research and manufacturing.

• Inspection timeframe: 5-day review of operations and compliance standards.
• Vertically integrated R&D and manufacturing ensure product quality and regulatory adherence.
• Facility approved by USFDA and other global regulators for pharmaceutical production.